SCHEMBL27833367

SCHEMBL27833367

CCN(OC(=O)C1CC1)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
HDAC6 Q9UBN7 2/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HRH3 Q9Y5N1 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
HSD11B1 P28845 1/20 0.32
MAPT P10636 1/20 0.30
THRA P10827 1/20 0.30
THRB P10828 1/20 0.30
GPR119 Q8TDV5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1771789 0.94 BTK (0.37) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL28612600 0.83 KMT2A (0.38) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL29239760 0.83 HRH3 (0.34) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL29239679 0.80 L3MBTL1 (0.36) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL1829857 0.79 SMN1; SMN2 (0.30)
SCHEMBL28534028 0.78 ALDH1A1 (0.39) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL27813334 0.77 HRH3 (0.36) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL1936374 0.77 HDAC6 (0.39) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL9171625 0.77 HDAC6 (0.50) NFKB1NFKB2RELAKMT2AALDH1A1
SCHEMBL20496118 0.75 HDAC6 (0.36) ALDH1A1TSHRHDAC6HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102112467-B Pyrimidine derivative as kinase inhibitors IRM LLC 2014-04-30 CN disclosed
CN-102112467-A Compounds and compositions as kinase inhibitors IRM LLC 2011-06-29 CN disclosed